The European Commission has approved mirvetuximab soravtansine for select patients with pretreated folate receptor–alpha (FRα)-positive, platinum-resistant ovarian cancer.
Jarni Greatorex, 18, was diagnosed with peritoneal mesothelioma in 2022 but was left in limbo for about a year as local doctors struggled to identify the cancer — which at that point had never been ...
A decade of research work has led to many medicinal innovations. These include a drug delivery platform for the treatment of peritoneal cancer, which resulted in the spin-off company NaDeNo. And today ...